Insect natural products and processes: New treatments for human disease

Insect Biochemistry and Molecular Biology

Volumn 41, Issue 10, 2011, Pages 747-769

  Ratcliffe, Norman A ^a,b   Mello, Cicero B ^c   Garcia, Eloi S ^a   Butt, Tariq M ^b   Azambuja, Patricia ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Anti cancer agents; Anticoagulants; Antimicrobial factors; Cantharidin; Folk medicine; Honey; Insect natural products; Maggots; Medicinal drugs; Silk; Venom

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ARTHROPOD VENOM; BIOLOGICAL PRODUCT; CANTHARIDIN;

ANIMAL; CHEMISTRY; DEBRIDEMENT; DRUG DEVELOPMENT; FEEDING BEHAVIOR; HONEY; HUMAN; INSECT; LARVA; REVIEW; SILK; TRADITIONAL MEDICINE; WOUND HEALING;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; ARTHROPOD VENOMS; BIOLOGICAL AGENTS; CANTHARIDIN; DEBRIDEMENT; DRUG DISCOVERY; FEEDING BEHAVIOR; HONEY; HUMANS; INSECTS; LARVA; MEDICINE, TRADITIONAL; SILK; WOUND HEALING;

ARTHROPODA; BACTERIA (MICROORGANISMS); HEXAPODA; HUMAN IMMUNODEFICIENCY VIRUS; MAMMALIA;

EID: 80051817300     PISSN: 09651748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ibmb.2011.05.007     Document Type: Review

References (304)

1. Adams M.D., Celniker S.E., Holt R.A., et al. The genome sequence of Drosophila melanogaster. Science 2000, 287:2185-2195.
2. Ahn M.Y., Shim S.H., Jeong H.K., Ryu K.S. Purification of a dimethyladenosine compound from silkworm pupae as a vasorelaxation substance. J. Ethnopharmacol. 2008, 117:115-122.
3. Akiyama N., Umeda I.O., Sogo S., et al. 5-S-GAD, a novel radical scavenging compound, prevents lens opacity development. Free Radic. Biol. Med. 2009, 46:511-519.
4. Aliwaga Y., Hume E.B.H., Lan J., Willcox M.D.P. Antimicrobial peptides: a potential role in ocular therapy. Clin. Exp. Opthalmol. 2001, 29:157-160.
5. Altincicek B., Vilcinskas A. Septic injury-inducible genes in medicinal maggots of the green blow fly Lucilia sericata. Insect Mol. Biol. 2009, 18:119-125.
6. Alvarez-Bravo J., Kurata S., Natori S. Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus. Biochem. J. 1994, 302:535-538.
7. An W.-W., Wang M.-W., Tashiro S.-I., et al. Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways. J. Korean Med. Sci. 2004, 19:560-566.
8. Andersen J.F. Structure and mechanism in salivary proteins from blood-feeding arthropods. Toxicon 2010, 56:1120-1129.
9. Andersen A.S., Sandvang D., Schnorr K.M., et al. A novel approach to the antimicrobial activity of maggot debridement therapy. J. Antimicrob. Chemother. 2010, 65:1646-1654.
10. Andreu D., Rivas L. Animal antimicrobial peptides: an overview. Biopolymers 1998, 47:415-433.
11. Anggraeni T., Ratcliffe N.A. Studies on cell-cell cooperation during phagocytosis by purified haemocyte populations of the wax moth Galleria mellonella. J. Insect Physiol. 1991, 37:453-460.
12. Apidianakis Y., Rahme L.G., Heitman J., et al. Challenge of Drosophila melanogaster with Cryptococcus neoformans and role of the innate immune response. Eukaryot. Cell 2004, 3:413-419.
13. Arbiser J.L., Kau T., Konar M., et al. Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis. Blood 2007, 109:560-565.
14. Argiolas A., Pisano J.J. Bombolitins, a new class of mast cell degranulating peptides from the venom of the bumblebee Megabombus pennsylvanicus. J. Biol. Chem. 1985, 260:1437-1444.
15. Argiolas A., Herring P., Pisano J.J. Amino acid sequence of bumblebee MCD peptide: a new mast cell degranulating peptide from the venom of the bumblebee Megabombus pennsylvanicus. Peptides 1985, 3:431-436.
16. Armstrong D.G., Mossel J., Short B., et al. Maggot debridement therapy: a primer. J. Am. Podiatr. Med. Assoc. 2002, 92:398-401.
17. Ayres J.S., Freitag N., Schneider D.S. Identification of Drosophila mutants altering defense of and endurance to Listeria monocytogenes. Genetics 2008, 178:1807-1815.
18. Baer W.S. The treatment of chronic osteomyelitis with the maggot (larva of the blow fly). J. Bone Joint Surg. 1931, 13:438-475.
19. Beard C.B., Cordon-Rosales C., Durvasula R.V. Bacterial symbionts of the Triatominae and their potential use in control of Chagas disease transmission. Annu. Rev. Entomol. 2002, 47:123-141.
20. Bexfield A., Nigam Y., Thomas S., Ratcliffe N.A. Detection and partial characterization of two antibacterial factors from the excretion/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus. Microbes Infect. 2004, 6:1297-1304.
21. Bexfield A., Bond A.E., Roberts E.C. The antibacterial activity against MRSA strains and other bacteria of a <500 Da fraction from maggot excretions/secretions of Lucilia sericata (Diptera: Calliphoridae). Microbes Infect. 2008, 10:325-333.
22. Bexfield A., Bond A.E., Morgan C. Amino acid derivatives from Lucilia sericata excretions/secretions may contribute to the beneficial effects of maggot therapy via increased angiogenesis. Br. J. Dermatol. 2010, 162:554-562.
23. Bikker F.J., Kaman-van-Zantan W.E., De Vries-van de Ruit A.-M.B.C., et al. Evaluation of the antibacterial spectrum of drosicin analogues. Chem. Biol. Drug Des. 2006, 68:148-153.
24. Blow N.S., Salomon R.N., Garrity K., et al. Vibrio cholorae infection of Drosophila melanogaster mimics the human disease cholera. PLoS Pathog. 2005, 1(1):e8. 10.1371/journal.ppat.0010008.
25. Boman H.G., Nilsson I., Rasmuson B. Inducible antibacterial defence system in Drosophila. Nature 1976, 237:232-235.
26. Bommarius B., Jenssen H., Elliott M., et al. Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides 2010, 31:1957-1965.
27. Borel J.F., Kis Z.L. The discovery and development of cyclosporine (Sandimmune). Transplant. Proc. 1991, 23:1867-1874.
28. Botas J. Drosophila researchers focus on human disease. Nat. Genet. 2007, 39:59.
29. Boulanger N., Bulet P., Lowenberger C. Antimicrobial peptides in the interactions between insects and flagellate parasites. Trends Parasitol. 2006, 22:262-268.
30. Bowden L., Dheilly N.M., Raftos D.A., et al. New immune systems: pathogen-specific host defence, life history strategies and hypervariable immune-response genes of invertebrates. ISJ 2007, 4:127-136.
31. Boxell A., Lee S.H.C., Jefferies R., et al. Pyrrhocoricin as a potential drug delivery vehicle for Cryptosporidium parvum. Exp. Parasitol. 2008, 119:301-303.
32. Brier T.J., Mellor I.R., Tikhonov D.B., et al. Contrasting actions of philanthotoxin-343 and philanthotoxin-(12) on human muscle nicotinic acetylcholine receptors. Mol. Pharmacol. 2003, 64:954-964.
33. Briggs J.D. Humoral immunity in lepidopterous larvae. J. Exp. Zool. 1958, 138:155-188.
34. Buchman J., Blair J.E. Maggots and their use in the treatment of chronic osteomyelitis. Surg. Gynecol. Obstet. 1932, 55:177-190.
35. Buku A., Condie B.A., Price J.A., Mezei M. [Ala12]MCD peptide: a lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors. J. Pept. Res. 2005, 66:132-137.
36. Buku A., Keselman I., Lupyan D., Mezei M., Price J.A. Effective mast cell degranulating peptide inhibitors of the IgE/FceRI receptor interaction. Chem. Biol. Drug Des. 2008, 72:133-139.
37. Bulet P., Stocklin R. Insect antimicrobial peptides: structures, properties and gene regulation. Protein Pept. Lett. 2005, 12:3-11.
38. Bulet P., Hetru C., Dimarcq J.-L., Hoffmann D. Antimicrobial peptides in insects: structure and function. Dev. Comp. Immunol. 1999, 23:329-344.
39. Carneiro-Lobo T.C., Konig S., Machado D.E. Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model. J. Thromb. Haemost. 2009, 7:1855-1864.
40. Cerovsky V., Slaninova J., Fucik V., et al. New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs. Peptides 2008, 29:992-1003.
41. Cerovsky V., Zdarek J., Fucik V., et al. Lucifensin, the long-sought antimicrobial factor of medicinal maggots of the blowfly, Lucilia sericata. Cell. Mol. Life Sci. 2010, 67:455-466.
42. Chalk R., Townson H., Ham P.J. Brugia pahangi: the effects of cecropins on microfilariae in vitro and in Aedes aegypti. Exp. Parasitol. 1995, 80:401-406.
43. Chambers L., Woodrow S., Brown A.P., et al. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br. J. Dermatol. 2003, 148:14-23.
44. Chamilos G., Lewis R.E., Hu J., et al. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9367-9372.
45. Chamilos G., Lionakis M.S., Lewis R.E., et al. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. J. Infect. Dis. 2006, 193:1014-1022.
46. Chen J., Lariviere W.R. The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword. Prog. Neurobiol. 2010, 92:151-183.
47. Chen J., Cantrell C.L., Shang H.-S., Rojas M.G. Piperideine alkaloids from the poison gland of the red imported fire ant (Hymenoptera: Formicidae). J. Agric. Food Chem. 2009, 57:3128-3133.
48. Chen X., Zhu F., Cao Y., Qiao S. Novel expression vector for secretion of cecropin AD in Bacillus subtilis with enhanced antimicrobial activity. Antimicrob. Agents Chemother. 2009, 53:3683-3689.
49. Chen Y.N., Cheng C.-C., Chen J.-C., et al. Norcantharidin-induced apoptosis is via the extracellular-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells. Br. J. Pharmacol. 2003, 140:461-470.
50. Cherniak E.P. Bugs as drugs, part 1: insects, the new alternative medicine for the 21st century?. Altern. Med. Rev. 2010, 15:124-135.
51. Chernysh S., Kim S.I., Bekker G., et al. Antiviral and antitumor peptides from insects. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:12628-12632.
52. Cho J.-H., Homma K., Kanegasaki S., Natori S. Activation of human neutrophils by a synthetic anti-microbial peptide, KLKLLLLLKLK-NH2, via cell surface calreticulin. Eur. J. Biochem. 1999, 266:878-885.
53. Choo Y.M., Lee K.S., Yoon H.J., et al. Molecular cloning and antimicrobial activity of bombolitin, a component of bumblebee Bombus ignitus venom. Comp. Biochem. Physiol. B 2010, 156:168-173.
54. Chu S.-T., Cheng H.-H., Huang C.-J., et al. Phospholipase A2-independent Ca2+ entry and subsequent apoptosis induced by melittin in human MG63 osteosarcoma cells. Life Sci. 2007, 80:364-369.
55. Chudzinski-Tavassi A.M., De-Sá-Júnior P.L., Simons S.M., et al. A new tick Kunitz type inhibitor, Amblyomin-X, induces tumor cell death by modulating genes related to the cell cycle and targeting the ubiquitin-proteasome system. Toxicon 2010, 56:1145-1154.
56. Church J.C.T. The traditional use of maggots in wound healing, and the development of larva therapy (biosurgery) in modern medicine. J. Altern. Complement. Med. 1996, 2:525-527.
57. Costa-Neto E.M. The use of insects in folk medicine in the state of Bahia, Northeastern Brazil, with notes on insects reported elsewhere in Brazilian folk medicine. Hum. Ecol. 2002, 30:245-263.
58. Costa-Neto E.M. Animal-based medicines: biological prospection and sustainable use of zootherapeutic resources. An. Acad. Bras. Ciênc. 2005, 77:33-43.
59. Costa-Neto E.M. Entomotherapy, or the medicinal use of insects. J. Ethnobiol. 2005, 25:93-114.
60. Coutinho-Abreu I.V., Zhu K.Y., Ramalho-Ortigao M. Transgenesis and paratransgenesis to control insect-borne diseases: current status and future challenges. Parasitol. Int. 2010, 59:1-8.
61. Cox C.R., Gilmore M.S. Native microbial colonization of Drosophila melanogaster and its use as a model of Enterococcus faecalis pathogenesis. Infect. Immun. 2007, 75:1565-1576.
62. Crane E.E. Archaeology of Beekeeping 1983, Duckworth, G. & Co Ltd, 360 pp.
63. Cudic M., Condie B.A., Weiner D.J., et al. Development of novel antibacterial peptides that kill resistant isolates. Peptides 2002, 23:2071-2081.
64. Danneels E.L., Rivers D.B., de Graaf D.C. Venom proteins of the parasitoid wasp Nasonia vitripennis: recent discovery of an untapped pharmacopee. Toxins 2010, 2:494-516.
65. D'Argenio D.A., Gallagher L.A., Berg C., Manoil C. Drosophila as a model host for Pseudomonas aeruginosa infection. J. Bacteriol. 2001, 183:1466-1471.
66. Dassanayake R.S., Silva Gunawardene Y.I.N., Tobe S.S. Evolutionary selective trends of insect/mosquito antimicrobial defensin peptides containing cysteine-stabilized a/b motifs. Peptides 2007, 28:62-75.
67. De Moura T.R., Oliveira F., Rodrigues G.C., et al. Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis. PLoS Negl. Trop. Dis. 2010, 4(6):e712. 10.1371/journal.pntd.0000712.
68. Diamond G., Beckloff N., Weinberg A., Kisich K.O. The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des. 2009, 15:2377-2392.
69. Dimarcq J.L., Zachary D., Hoffmann J.A., et al. Insect immunity. Expression of the two major inducible antibacterial peptides, defensin and diptericin, in Phormia terranovae. EMBO J. 1990, 9:2507-2515.
70. Dionne M.S., Ghori N., Schneider D.S. Drosophila melanogaster is a genetically tractable model host for Mycobacterium marinum. Infect. Immun. 2003, 71:3540-3550.
71. Dorn D.C., Kou C.A., Png K.J., Moore M.A.S. The effect of cantharidins on leukemic stem cells. Int. J. Cancer 2009, 124:2186-2199.
72. Dossey A.T. Insects and their chemical weaponry: new potential for drug discovery. Nat. Prod. Rep 2010, 27:1737-1757.
73. Dumville J.C., Worthy G., Bland J.M., et al. Larval therapy for leg ulcers (VenUS II): randomised controlled trial. BMJ 2009, 338:b773.
74. Durvasula R.V., Gumbs A., Panackal A., Kruglov O., et al. Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:3274-3278.
75. Easton D.M., Nijnik A., Mayer M.L., Hancock R.E.W. Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 2009, 27:582-590.
76. Eisner T., Smedley S.R., Young D.K., et al. Chemical basis of courtship in a beetle (Neopyrochroa flabellata): cantharidin as precopulatory "enticing" agent. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:6494-6498.
77. Eisner T., Eisner M., Siegler M. Secret Weapons: Defense of Insects, Spiders, Scorpions, and Other Many-legged Creatures 2005, Belknap Press of Harvard University Press, Cambridge, MA.
78. Elkington R.A., Humphries M., Commins M., et al. A Lucilia cuprina excretory-secretory protein inhibits the early phase of lymphocyte activation and subsequent proliferation. Parasite Immunol. 2009, 31:750-765.
79. Engstrom Y., Kadalayil L., Sun S.C., et al. kB-like motifs regulate the induction of immune genes in Drosophila. J. Mol. Biol. 1993, 232:327-333.
80. Enright M.C. The evolution of a resistant pathogen-the case of MRSA. Curr. Opin. Pharmacol. 2003, 3:474-479.
81. Erdman G.R. Antibacterial activity of myasis-causing flies. Parasitol. Today 1987, 3:214-216.
82. Erdman G.R., Khalil S.K.W. Isolation and identification of two antibacterial agents produced by a strain of Proteus mirabilis isolated from the larvae of the screwworm (Cochliomyea hominivorax) (Diptera: Calliphoridae). J. Med. Entomol. 1986, 23:208-211.
83. Evans P. Larvae therapy and venous leg ulcers: reducing the "yuk" factor. J. Wound Care 2002, 11:407-408.
84. Fan Y.Z., Zhao Z.M., Fu J.Y., Chen C.Q. Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo. Zhonghua Wai Ke Za Zhi 2006, 44:618-622.
85. Feldhaar H., Gross R. Immune reactions of insects on bacterial pathogens and mutualists. Microbes Infect. 2008, 10:1082-1088.
86. Feng Y., Zhao M., He Z., Chen Z., Sun L. Research and utilisation of medicinal insects in China. Entomol. Res. 2009, 39:313-316.
87. Ferrandon D., Imler J.L., Hetru C., Hoffmann J.A. The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections. Nat. Rev. Immunol. 2007, 7:862-874.
88. Ferre R., Melo M.N., Correia A.D., et al. Synergistic effects of the membrane actions of cecropin-melittin antimicrobial hybrid peptide BP100. Biophys. J. 2009, 96:1815-1827.
89. Francischetti I.M.B. Platelet aggregation inhibitors from hematophagous animals. Toxicon 2010, 56:1130-1144.
90. Francischetti I.M.B., Mather T.N., Ribeiro J.M.C. Tick saliva is a potent inhibitor of endothelial cell proliferation and angiogenesis. Thromb. Haemost. 2005, 94:167-174.
91. Francischetti I.M.B., Sá-Nunes A., Mans B.J., et al. The role of saliva in tick feeding. Front. Biosci. 2009, 14:2051-2088.
92. Gevod V.S., Birdi K.S. Melittin and the 8-26 fragment. Differences in ionophoric properties as measured by monolayer method. Biophys. J. 1984, 45:1079-1083.
93. Greish K., Araki K., Li D., et al. Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors. Biomacromolecules 2009, 10:2183-2188.
94. Gross J., Schumacher K., Schmidtberg H., Vilcinskas A. Protected by fumigants: beetle perfumes in antimicrobial defense. J. Chem. Ecol. 2008, 34:179-188.
95. Gullan P.J., Cranston P. The Insects: An Outline of Entomology 2010, Wiley-Blackwell. fourth ed.
96. Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol. Aspects Med. 2006, 27:1-93.
97. Hajnická V., Vancová-Štibrániová I., Slovák M., et al. Ixodid tick salivary gland products target host wound healing growth factors. Int. J. Parasitol. 2011, 41:213-223.
98. Hancock R.E.W., Chapple D.S. Peptide antibiotics. Antimicrob. Agents Chemother. 1999, 43:1317-1323.
99. Harris L.G., Bexfield A., Nigam Y., et al. Disruption of Staphylococcus epidermidis biofilms by medicinal maggot Lucilia sericata excretions/secretions. Int. J. Artif. Organs 2009, 32:555-564.
100. Hattori N., Nomoto H., Fukumitsu H., et al. AMP N1-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC cells via signalling by protein kinase A independent of that by mitogen-activated protein kinase. eCAM 2010, 7:63-68.
101. Hennessy E.J., Parker A.E., O'Neill L.A.J. Targeting toll-like receptors: emerging therapeutics?. Nat. Rev. Drug Discov. 2010, 9:293-307.
102. Hilpert K., Fjell C.D., Cherkasov A. Short linear cationic antimicrobial peptides: screening, optimizing, and prediction. Methods Mol. Biol. 2008, 494:127-159.
103. Hirsh J., O'Donnell M., Eikelboom J.W. Beyond unfractionated heparin and warfarin current and future advances. Circulation 2007, 116:552-560.
104. Hoffman D.R. Allergens in Hymenoptera venom. XXV: the amino acid sequences of antigen 5 molecules and the structural basis of antigenic cross-reactivity. J. Allergy Clin. Immunol. 1993, 92:707-716.
105. Hoffman D.R. Ant venoms. Curr. Opin. Allergy Clin. Immunol. 2010, 10:342-346.
106. Hoffmann J.A. The immune response of Drosophila. Nature 2003, 426:33-38.
107. Holle L., Song W., Holle F., et al. A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo. Int. J. Oncol. 2003, 22:93-98.
108. Horobin A.J., Shakessheff K.M., Woodrow S., et al. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br. J. Dermatol. 2003, 148:923-933.
109. Horobin A.J., Kevin M., Shakesheff K.M., Pritchard D.I. Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions. J. Invest. Dermatol. 2006, 126:1410-1418.
110. Hoskin D.W., Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta 2008, 1778:357-375.
111. Huan S.K., Lee H.H., Liu D.Z., Wu C.C., Wang C.C. Cantharidin-induced cytotoxicity and cyclooxygenase 2 expression in human bladder carcinoma cell line. Toxicology 2006, 223:136-143.
112. Huang Y., Liu Q., Liu K., et al. Suppression of growth of highly-metastatic human breast cancer cells by norcantharidin and its mechanisms of action. Cytotechnology 2009, 59:201-208.
113. Huberman L., Gollop N., Mumcuoglu K.Y., et al. Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Med. Vet. Entomol. 2007, 21:127-131.
114. Imler J.-L., Bulet P. Antimicrobial peptides in Drosophila: structures, activities and gene regulation. Mechanisms of Epithelial Defense. Chem. Immunol. Allergy 2005, 86:1-21. Karger, Basel. D. Kabelitz, J.M. Schroder (Eds.).
115. Ishii K.J., Uematsu S., Akira S. "Toll" gates for future immunotherapy. Curr. Pharm. Des. 2006, 12:4135-4142.
116. Itoh A., Ohsawa F., Ohkuma Y., Natori S. Participation of tumor killing factor in the antitumor effect of Sarcophaga lectin. FEBS Lett. 1986, 201:37-40.
117. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
118. Iwasaki T., Ishibashi J., Tanaka H., et al. Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface. Peptides 2009, 30:660-668.
119. Izuta H., Chikaraishi Y., Shimazawa M., et al. 10-hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells. eCam 2009, 6:489-494.
120. Jayaraman V., Usherwood P.N., Hess G.P. Inhibition of nicotinic acetylcholine receptor by philanthotoxin-343: kinetic investigations in the microsecond time region using a laser-pulse photolysis technique. Biochemistry 1999, 38:11406-11414.
121. Jiang S.J. Anti-cancer insect medicinal materials in China. J. Chin. Med. Mater. 1990, 13:11-14.
122. Jin X., Me H., Li X., et al. Apoptosis-inducing activity of the antimicrobial peptide cecropin of Musca domestica in human hepatocellular carcinoma cell line BEL-7402 and the possible mechanism. Acta Biochim. Biophys. Sin. 2010, 259-265.
123. Jiravanichpaisal P., Lee B.L., Soderhall K. Cell-mediated immunity in arthropods: hematopoiesis, coagulation, melanization and opsonisation. Immunobiology 2006, 211:213-236.
124. Jull A.B., Rodgers A., Walker N. Honey as a topical treatment for wounds. Cochrane Database of Syst. Rev. 2008, (Issue 4):CD00508. Art. No.: CD005083, 3pub2. 10.1002/14651858.
125. Kavanagh K., Reeves E. Insect and mammalian innate immune responses are much alike. Microbe 2007, 2:596-599.
126. Kawabata T., Mitsui H., Yokota K., Ishino K., Oguma K., Sano S. Induction of antibacterial activity in larvae of the blowfly Lucilia sericata by an infected environment. Med. Vet. Entomol. 2010, 24:375-381.
127. Kawada H., Kojima M., Kimura T., et al. Effect of 5-S-GAD on UV-B-induced cataracts in rats. Jpn. J. Ophthalmol. 2009, 53:531-535.
128. Kawai T., Akira S. TLR signaling. Semin. Immunol. 2007, 19:24-32.
129. Kellner R.L.L. Molecular identifuication of an endosymbiotic bacterium associated with pederin biosynthesis in Paederus sabaeus (Coleeoptera: Staphylinidae). Insect Biochem. Mol. Biol. 2002, 32:389-395.
130. Kerridge A., Lappin-Scott H., Stevens J. Antibacterial properties of larval secretions of the blowfly, Lucilia sericata. Med. Vet. Entomol. 2005, 19:333-337.
131. King T.P., Jim S.Y., Wittkowski K.M. Inflammatory role of two venom components of yellow jackets (Vespula vulgaris): a mast cell degranulating peptide mastoparan and phospholipase A1. Int. Arch. Allergy Immunol. 2003, 131:25-32.
132. King P., Spangfort M.D. Structure and biology of stinging insect venom allergens. Int. Arch. Allergy Immunol. 2000, 123:99-106.
133. Klein E., Smith D.L., Laxminarayan R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg. Infect. Dis. 2009, 15:1925-1930.
134. Koburova K.L., Michailova S.G., Shkenderov S.V. Further investigation on the anti-inflammatory properties of adolapin-bee venom polypeptide. Acta Physiol. Pharmacol. Bulg. 1985, 11:50-55.
135. Koh C.Y., Kini R.M. Molecular diversity of anticoagulants from haematophagous animals. Thromb. Haemost. 2009, 102:437-453.
136. Kok S.H., Chui C.H., Lam W.S., et al. Apoptotic activity of novel synthetic cantharidin analogs on hepatoma cell lines. Int. J. Mol. Med. 2006, 17:945-949.
137. Kokoza K., Ahmed A., Shin S.W., et al. Blocking of Plasmodium transmission by cooperative action of cecropin A and defensin A in transgenic Aedes aegypti mosquitoes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8111-8116.
138. Kono T., Watanabe M., Kishimoto T., et al. Cytotoxic activity of pierisin, from the cabbage butterfly, Pieris rapae, in various human cancer cell lines. Cancer Lett. 1999, 137:75-81.
139. Kondo T., Ikenaka K., Fujimoto I., et al. K+ channel involvement in induction of synaptic enhancement by mast cell degranulating (MCD) peptide. Neurosci. Res. 1992, 13:207-216.
140. Koriyama Y., Ohno M., Kimura T., Kato S. Neuroprotective effects of 5-S-GAD against oxidative stress-induced apoptosis in RGC-5 cells. Brain Res. 2009, 1296:187-195.
141. Koyama K., Wakabayashi K., Masutani M., et al. Presence in Pieris rapae of cytotoxic activity against human carcinoma cells. Jpn. J. Cancer Res. 1996, 87:1259-1262.
142. Kuhn J., Pettersson E.M., Feld B., et al. Selective transport systems mediate sequestration of plant glucosides in leaf beetles: a molecular basis for adaptation and evolution. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:13808-13813.
143. Kurokawa K., Hamamoto H., Matsuo M., et al. Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model. Antimicrob. Agents Chemother. 2009, 53:4025-4027.
144. Kwakman P.H.S., Te Velde A.J., De Boer L., et al. How honey kills. FASEB J. 2010, 24:2576-2582.
145. Labuda M., Trimnel A.R., Lickova M., et al. An antivector vaccine protects against a lethal vector-borne pathogen. PLoS Pathog. 2006, 2(4):e27. 10.1371/journal.ppat.0020027.
146. Lamy C., Goodchild S.J., Weatherall K.L., et al. Allosteric block of K(Ca)2 channels by apamin. J. Biol. Chem. 2010, 285:27067-27077.
147. Lander E.S., Linton L.M., Birren B., et al. International human genome sequencing consortium. Initial sequencing and analysis of the human genome. Nature 2001, 409(6822):860-921.
148. Lange C., Marvin L., Macual A., et al. Determination of the amino acid sequence of apamin by tandem mass spectrometry. Rapid Commun. Mass Spectrom. 1994, 8:539-543.
149. Lavine M.D., Strand M.R. Insect hemocytes and their role in immunity. Insect Biochem. Mol. Biol. 2002, 32:1295-1309.
150. Leather S. Taxonomic chauvinism threatens the future of entomology. Biologist 2009, 56:10-13.
151. Leclercq S., Thirionet I., Broeders F., et al. Absolute configuration of solenopsins, venom alkaloids of the fire ants. Tetrahedron 1994, 50:8464-8478.
152. Lee J.Y., Boman A., Sun C.X., et al. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:9159-9162.
153. Leem J.Y., Nishimura C., Kurata S., et al. Purification and characterisation of N-β-alanyl-5-S-glutathionyl-3-4-dihydroxyphenylalanine, a novel antibacterial substance of Sarcophaga peregrina (fleshfly). J. Biol. Chem. 1996, 271:13573-13577.
154. Lemaitre B., Hoffmann J. The host defense of Drosophila melanogaster. Annu. Rev. Immunol. 2007, 25:697-743.
155. Lemaitre B., Kromer-Metzger E., Michaut L., et al. A recessive mutation, immune deficiency (IMD), defines two distinct control pathways in the Drosophila host defense. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9465-9469.
156. Lerrer B., Zinger-Yosozich K.D., Avraham B., et al. Honey and royal jelly, like human milk, abrogate lectin-dependent infection preceding Pseudomonas aeruginosa adhesion. ISME J. 2007, 1:149-155.
157. Li F., Awale S., Zhang H., et al. Chemical constituents of propolis from Mynanmar and their preferential cytotoxicity against a human pancreatic cancer cell line. J. Nat. Prod. 2009, 72:1283-1287.
158. Li W., Li X., Chen Z., et al. Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell cycle arrest and apoptosis. Cancer Sci. 2010, 101:1226-1233.
159. Libersat F. Wasp uses venom cocktail to manipulate the behavior of its cockroach prey. J. Comp. Physiol. A. Neuroethol. Sens. Neural Behav. Physiol. 2003, 189:497-508.
160. Liu D., Chen Z. The effects of cantharidin and cantharidin derivatives on tumour cells. Anticancer Agents Med. Chem. 2009, 9:392-396.
161. Liu Z., Wu X., Wang J., Huang F. Molecular evidences for the biosynthesis of pederin by endosymbiont. Agric. Sci. China 2009, 8:1339-1350.
162. Lubke L.L., Garon C.F. The antimicrobial agent melittin exhibits powerful in vitro inhibitory effects on the Lyme disease spirochaete. Clin. Infect. Dis. 1997, 25(Suppl. 1):S48-S51.
163. Mack P., Ha X.-F., Cheng L.-Y. Efficacy of intra-arterial norcantharidin in suppressing tumour 14C-labelled glucose oxidative metabolism in rat Morris. HPB Surg. 1996, 10:65-72.
164. MacIntosh A.C., Victoria R., Kearns V.R., et al. Skeletal tissue engineering using silk biomaterials. J. Tissue Eng. Regen. Med. 2008, 2:71-80.
165. Majtan J., Kovacova E., Bilikova K., Siuth J. The immunostimulatory effect of the recombinant apalbumin 1-major honeybee royal jelly protein-on TNF-release. Int. Immunopharmacol. 2006, 6:269-278.
166. Majtan J., Kumar P., Majtan T., et al. Effect of honey and its major royal jelly protein 1 on cytokine and MMP-9 mRNA transcripts in human keratinocytes. Exp. Dermatol. 2010, 19:e73-e79.
167. Mamararis V.J., Lampropoulou M. Regulators and signalling in insect haemocyte immunity. Cell Signal. 2009, 21:186-195.
168. Mandal B.B., Kapoor S., Kundu S.C. Silk fibroin/polyacrylamide semi-interpenetrating network hydrogels for controlled drug release. Biomaterials 2009, 30:2826-2836.
169. Maritz-Olivier C., Stutzer C., Jongejan F., et al. Tick anti-hemostatics: targets for future vaccines and therapeutics. Trends Parasitol. 2007, 23:397-407.
170. Markwardt F., Walsmann P. Pure synthesis and analysis of thrombin inhibitor hirudin. H-S. Z. Physiol. Chem. 1967, 348:1381.
171. Marr A.K., Gooderham W.J., Hancock R.E.W. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr. Opin. Pharmacol. 2006, 6:468-472.
172. Matysiak J., Schmelzer C.E.H., Neubert R.H.H., Kokot Z.J. Characterization of honeybee venom by MALDI-TOF and nanoESI-QqTOF mass spectrometry. J. Pharm. Biomed. Anal. 2011, 54:273-278.
173. Medzhitov R., Preston Hurlburt P., Janeway C.A. A human homologue of Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
174. Meenakshisundaram R., Sweni S., Thiramalaikolundusubramanian P. Hypothesis of snake and insect venoms against human immunodeficiency virus: a review. AIDS Res. Ther. 2009, 6:25.
175. Meinel L., Betz O., Fajardo R., et al. Silk based biomaterials to heal critical sized femur defects. Bone 2006, 39:922-931.
176. Mendes M.A., Palma M.S. Two new bradykinin-related peptides from the venom of the social wasp Protopolybia exigua (Saussure). Peptides 2006, 27:2632-2639.
177. Mendes M.A., de Souza B.M., Palma M.S. Structural and biological characterization of three novel mastoparan peptides from the venom of the neotropical social wasp Protopolybia exigua (Saussure). Toxicon 2005, 45:101-106.
178. Meylaers K., Cerstiaens A., Vierstraete E., et al. Antimicrobial compounds of low molecular mass are constitutively present in insects: characterisation of β-alanyl-tyrosine. Curr. Pharm. Des. 2003, 9:159-174.
179. Moon D.-O., Park S.-Y., Lee K.-J., et al. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int. Immunopharmacol. 2007, 7:1092-1101.
180. Monteiro M.C., Romão PR.T., Soares A.M. Pharmacological perspectives of wasp venom. Protein Pept. Lett. 2009, 2009(16):944-952.
181. Montfort W.R., Weichsel A., Andersen J.F. Nitrophorins and related antihemostatic lipocalins from Rhodnius prolixus and other blood-sucking arthropods. Biochim. Biophys. 2000, 1482:110-118.
182. Moran P.C. The use of honey in the treatment of wounds. J. Wound Care 1999, 8:415-418.
183. Moreira L.A., Ito J., Ghosh G., et al. Bee venom phospholipase inhibits malaria parasite development in transgenic mosquitoes. J. Biol. Chem. 2002, 277:40839-40843.
184. Mortari M.R., Cunha A.O.S., Carolino R.O.G., et al. Inhibition of acute nociceptive responses in rats after i.c.v. injection of Thr6-bradykinin, isolated from the venom of the social wasp, Polybia occidentalis. Br. J. Pharmacol. 2007, 151:860-869.
185. Mukherjee K., Domann E., Hain T. The greater wax moth Galleria mellonella as an alternative model host for human pathogens. Insect Biotechnology 2010, 3-14. Springer, Dordrecht Heidelberg London New York. A. Vilsinskas (Ed.).
186. Mumcuoglu K.Y., Ingber A., Gilead L., et al. Maggot therapy for the treatment of intractable wounds. Int. J. Dermatol. 1999, 8:623-627.
187. Murata K., Shinada T., Ohfune Y., et al. Novel mastoparan and protonectin analogs isolated from a solitary wasp, Orancistrocerus drewseni drewseni. Amino Acids 2009, 37:389-394.
188. Mylonakis E., Moreno R., El Khoury J.B., et al. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect. Immun. 2005, 73:3842-3850.
189. Naitza S., Ligoxygakis P. Antimicrobial defences in Drosophila: the story so far. Mol. Immunol. 2004, 40:887-896.
190. Natori S. Molecules participating in insect immunity of Sarcophaga peregrina. Proc. Jpn. Acad. Ser. B. 2010, 86:927-938.
191. Nguyen L.T., Chau J.K., Perry N.A., et al. Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs. PLoS ONE 2010, 5(9):e12684. 10.1371/journal.pone.0012684.
192. Nigam Y., Bexfield A., Thomas S., Ratcliffe N.A. Maggot therapy: the science and implication for CAM. Part I: history and bacterial resistance. Evid. Based Complement. Alternat. Med. 2006, 3:223-227. 10.1093/ecam/nel021.
193. Nigam Y., Bexfield A., Thomas S., Ratcliffe N.A. Maggot therapy: the science and implication for CAM. Part II: maggots combat infection. Evid. Based Complement. Alternat. Med. 2006, 3:303-308. 10.1093/ecam/nel022.
194. Nijnik A., Hancock R.E.W. Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections. Emerg. Health Threats J. 2009, 10.3134/ehtj.09.001.
195. Noto P.B., Abbadessa A., Cassone M., et al. Alternative stabilities of a proline-rich antibacterialpeptide in vitro and in vivo. Protein Sci. 2008, 17:1249-1255.
196. Numata K., Kaplan D.L. Silk-based delivery systems of bioactive molecules. Adv. Drug Deliv. Rev. 2010, 62:1497-1508.
197. Numata K., Subramanian B., Currie H.A., Kaplan D.L. Bioengineered silk protein-based gene delivery systems. Biomaterials 2009, 30:5775-5784.
198. Okamoto I., Yoshifumi T., Toshio K., Keizo K., et al. Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci. 2003, 73:2029-2045.
199. Orth J.H.C., Schorch B., Boundy S., et al. Cell-free synthesis and characterization of a novel cytotoxic pierisin-like protein from the cabbage butterfly Pieris rapae. Toxicon 2010, 10.1016/toxicon.2010.11.011.
200. Osswald I.K., Galan A., Bowie D. Light triggers expression of philanthotoxin-insensitive Ca2+-permeable AMPA receptors in the developing rat retina. J. Physiol. 2007, 582:95-111.
201. Otto M. Bacterial sensing of antimicrobial peptides. Contrib. Microbiol. 2009, 16:136-149.
202. Otvos L. The short proline-rich antibacterial peptide family. Cell. Mol. Life Sci. 2002, 59:1138-1150.
203. Otvos L., Bokonyi K., Varga I., et al. Insect peptides with improved protease-resistance protect mice against bacterial infection. Protein Sci. 2000, 9:742-749.
204. Ourth D.D. Antiviral activity against human immunodeficiency virus-1 in vitro by myristoylated-peptide from Heliothis virescens. Biochem. Biophys. Res. Commun. 2004, 320:190-196.
205. Palma M.S. Insect Venom Peptides in, Handbook of Biologically Active Peptides 2006, 389-396. Elsevier, Chapter 56. A. Kastin (Ed.).
206. Park C., Lee D.G. Melittin induces apoptotic features in Candida albicans. Biochem. Biophys. Res. Commun. 2010, 394:170-172.
207. Park H.J., Lee H.J., Choi M.S., et al. JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. J. Inflamm. 2008, 5:7. 10.1186/1476-9255-5-7.
208. Park J.H., Jeong Y.-J., Park K.-K., et al. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-κB and AP-1-dependent MMP-9 expression. Mol. Cells 2010, 29:209-215.
209. Parnes A., Lagan K.M. Larval therapy in wound management: a review. Int. J. Clin. Pract. 2007, 61:488-493.
210. Pavillard E.R., Wright E.A. An antibiotic from maggots. Nature 1957, 180:916-917.
211. Pemberton R.W. Insects and other arthropods used as drugs in Korean traditional medicine. J. Ethnopharmacol. 1999, 65:207-216.
212. Peng F., Wei Y.Q., Tian L., et al. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand. J. Cancer Res. Clin. Oncol. 2002, 128:223-230.
213. Pham L.N., Dionne M.S., Shirasu-Hiza M., Schneider D.S. A specific primed immune response in Drosophila is dependent on phagocytes. PLoS Pathog. 2007, 3(3):e26. 10.1371/journal.ppat.0030026.
214. Picolo G., Hisada M., Moura A.B., et al. Bradykinin-related peptides in the venom of the solitary wasp Cyphononyx fulvognathus. Biochem. Pharmacol. 2010, 79:478-486.
215. Piek T., Hue B., Mantel P., et al. Threonine6-bradykinin in the venom of the wasp Colpa interrupta (F.) presynaptically blocks nicotinic synaptic transmission in the insect CNS. Comp. Biochem. Physiol. 1990, 96C:157-162.
216. Pillai A., Ueno S., Hong Zhang H., et al. Cecropin P1 and novel nematode cecropins: bacterial-inducible antimicrobial peptide family in the nematode Ascaris suum. Biochem. J. 2005, 390:207-214.
217. Poltorak A., He X., Smirnova I., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
218. Power E. Impact of antibiotic restrictions: the pharmaceutical perspective. Clin. Microbiol. Infect. 2006, 12:25-34.
219. Prete P.E. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci. 1997, 60:505-510.
220. Pritchard, D.I., Horobin, A.J., Brown, A., et al., 2007. Chymotrypsin from Lucilia sericata larvae and its use for the treatment of wounds. United States Patent Application 20100008898, filed 05/31/2007, http://www.freepatentsonline.com/y2010/0008898.html.
221. Putz T., Ramoner R., Gander H., et al. Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells. Cancer Immunol. Immunother. 2007, 56:627-640.
222. Pye A.E., Boman H.G. Insect immunity. III. Purification and partial characterization of immune protein P5 from hemolymph of Hyalophora cecropia pupae. Infect. Immun. 1977, 17:408-414.
223. Ratcliffe N.A., Whitten M.M.A. Vector immunity. Microbe-vector Interactions in Vector-borne Diseases. Society for General Microbiology Symposium 63 2004, 199-262. Cambridge University Press, Cambridge. S.H. Gillespie, G.L. Smith, A. Osbourn (Eds.).
224. Rauh R., Kahl S., Boechzelt H., et al. Molecular biology of cantharidin in cancer cells. Chin. Med. 2007, 2:8.
225. Reiter L.T., Potocki L., Chien S., et al. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 2001, 11:1114-1125.
226. Reitinger S., Boroviak T., Laschober G.T., et al. High-yield recombinant expression of the extremophile enzyme, bee hyaluronidase in Pichia pastoris. Protein Expr. Purif. 2008, 57:226-233.
227. Remoue F., Cisse B., Ba F., et al. Evaluation of the antibody response to Anopheles salivary antigens as a potential marker of risk of malaria. Trans. R. Soc.Trop. Med. Hyg. 2006, 100:363-370.
228. Ribeiro J.M.C., Arca B. From sialomes to the sialoverse: an insight into salivary potion of blood-feeding insects. Adv. Insect Physiol. 2009, 37:59-118.
229. Ribeiro J.M.C., Walker F.A. High affinity histamine-binding and antihistamine activity of the salivary nitric oxide-carrying heme protein (nitrophorin) of Rhodnius prolixus. J. Exp. Med. 1994, 180:2251-2257.
230. Ribeiro J.M.C., Mans B.J., Arcà B. An insight into the sialome of blood-feeding Nematocera. Insect Biochem. Mol. Biol. 2010, 40:767-784.
231. Rock F.L., Hardiman G., Timans J.C., et al. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:588-593.
232. Rozgonyi F., Szabo D., Kocsis B., et al. The antibacterial effect of a proline-rich antibacterial peptide A3-APO. Curr. Med. Chem. 2009, 16:3996-4002.
233. Ryu M.J., Anikin V., Hong S.H., et al. Activation of NF-kappaB by alloferon through down-regulation of antioxidant proteins and IkappaBalpha. Mol. Cell. Biochem. 2008, 313:91-102.
234. Saido-Sakanaka H., Momotani E., Yamada H., et al. Effect of a synthetic peptide designed on the basis of the active site of insect defensins on the proliferation of methicillin-resistant Staphylococcus aureus under the condition of external application. J. Insect Biotech. Sericol. 2005, 74:15-20.
235. Sang Y., Blecha F. Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics. Anim. Health Res. Rev. 2008, 9:227-235.
236. Santos A., Ribeiro J.M.C., Lehane M.J., et al. The sialotranscriptome of the blood-sucking bug Triatoma brasiliensis (Hemiptera, Triatominae). Insect Biochem. Mol. Biol. 2007, 37:702-712.
237. Schmid-Hempel P. Evolutionary ecology of insect immune defences. Annu. Rev. Entomol. 2005, 50:529-551.
238. Schneider B.S., Soong L., Coffey L.L., et al. Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection. PLoS ONE 2010, 5(7):e11704. 10.1371/journal.pone.0011704.
239. Schweizer F. Cationic amphiphilic peptides with cancer-selective toxicity. Eur. J. Pharmacol. 2009, 625:190-194.
240. Scully L.R., Bidochka M.J. Developing insect models for the study of current and emerging human pathogens. FEMS Microbiol. Lett. 2006, 263:1-9.
241. Sharma S.V. Melittin resistance: a counterselection for ras transformation. Oncogene 1992, 7:193-201.
242. Shen L.-R., Ding M.-H., Zhang L.-W., et al. Expression of a bee venom phospholipase A2 from Apis cerana cerana in the baculovirus-insect cell. J. Zhejiang Univ-Sci B (Biomed. & Biotechnol.) 2010, 11:342-349.
243. Shen Y., Lao X.G., Chen Y., Zhang H.Z., Xu X.X. High-level expression of cecropin X in Escherichia coli. Int. J. Mol. Sci. 2007, 8:478-491.
244. Sherman R.A. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care 2003, 26:446-451.
245. Sherman R.A. Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century. J. Diabetes Sci. Technol. 2009, 3:336-344.
246. Sherman R.A., Hall M.J.R., Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu. Rev. Entomol. 2000, 45:55-81.
247. Shi W.J., Zhang S.F., Zhang C.X., Cheng J.A. Cloning and comparative analysis of the venom prepromelittin genes from four wasp species. Acta Genetica Sin. 2003, 30:555-559.
248. Shiga A., Kakamu S., Sugiyama Y., et al. Acute toxicity of pierisin-1, a cytotoxic protein from Pieris rapae, in mouse and rat. J. Toxicol. Sci. 2006, 31:123-137.
249. Shkenderov S., Koburova K. Adolapin-a newly isolated analgetic and anti-inflammatory polypeptide from bee venom. Toxicon 1982, 20:317-321.
250. Shlaes D.M., Projan S.J., Edwards J.E. Antibiotic discovery: state of the state. ASM News 2004, 70(60):275-281.
251. Simmons S. A bactericidal principle in excretions of surgical maggots which destroys important etiological agents of pyogenic infections. J. Bacteriol. 1935, 30:253-267.
252. Slocinska M., Marciniak P., Rosinski G. Insects antiviral and anticancer peptides: new leads for the future?. Protein Pept. Lett. 2008, 15:578-585.
253. Smith A.G., Powis R.A., Pritchard D.I., et al. Greenbottle (Lucilia sericata) larval secretions delivered from a prototype hydrogel wound dressing accelerate the closure of model wounds. Biotechnol. Prog. 2006, 22:1690-1696.
254. Soman N.R., Baldwin S.L., Hu G., et al. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumour cells in mice, reducing growth. J. Clin. Invest. 2009, 119:2830-2842.
255. Somerfield S.D., Stach J.L., Mraz C., et al. Bee venom melittin blocks neutrophil O2- production. Inflammation 1986, 10:175-182.
256. Son D.J., Lee J.W., Lee Y.H., et al. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol.Ther. 2007, 115:246-270.
257. Southcott R.V. Injuries from coleoptera. Med. J. Aust. 1989, 151:654-659.
258. Stanley D., Miller J., Tunaz H. Eicosanoid actions in insect immunity. J. Innate Immun. 2009, 1:282-290.
259. Steenvoorde P., Jacobi C.E., van Doorn L., Oskam J. Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome - a study on 101 patients with 117 wounds. Ann. R. Coll. Surg. Engl. 2007, 89:596-602.
260. Steinberg D.A., Hurst M.A., Fujii C.A., et al. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 1997, 41:1738-1742.
261. Stewart R.J., Wang C.S. Adaptation of caddisfly larval silks to aquatic habitats by phosphorylation of H-fibroin serines. Biomacromolecules 2010, 11:969-974.
262. Stubbs M.T., Bode W. The clot thickens: clues provided by thrombin structure. Trends Biochem. Sci. 1995, 20:23-28.
263. Stutzmann J.M., Wahl F., Pratt J., et al. Neuroprotective profile of riluzole in in vivo models of acute neurodegenerative diseases. CNS Drug Rev. 1997, 3:83-101.
264. Suttmann H., Retz M., Paulsen F., et al. Antimicrobial peptides of the cecropin-family show potent antitumor activity against bladder cancer cells. BMC Urol. 2008, 8:5. 10.1186/1471-2490-8-5.
265. Szybala C., Pritchard E.M., Lusardi T.A., et al. Antiepileptic effects of silk-polymer based adenosine release in kindled rats. Exp. Neurol. 2009, 219:126-135.
266. Tabachnick W.J. Pharmacological factors in the saliva of blood-feeding insects. Implications for vesicular stomatitis epidemiology. Trop. Vet. Dis. 2000, 916:444-452.
267. Tan L., Schedl P., Song H.-J., Garza G., Konsolaki M. The Toll-NFkB signalling pathway mediates the neuropathological effects of the human Alzheimer's Aβ42 polypeptide in Drosophila. PLoS ONE 2008, 3(12):e3966. 10.1371/journal.pone.0003966.
268. Tanaka-Azevedo A.M., Morais-Zani K., Torquato R.J.S., Tanaka A.S. Thrombin inhibitors from different animals. J. Biomed. Biotechnol. 2010, 9. Article ID 641025. 10.1155/2010/641025.
269. Teramoto H., Kameda T., Tamada Y. Preparation of gel film from Bombyx mori silk sericin and its characerization as a wound dressing. Biosci. Biotechnol. Biochem. 2008, 72:3189-3196.
270. Terwilliger T.C., Eisenberg D. The structure of melittin: II. Interpretation of the structure. J. Biol. Chem. 1982, 257:6016-6022.
271. The genome of a lepidopteran model insect, the silkworm Bombyx mori. Insect Biochem. Mol. Biol. 2008, 38:1036-1045. The International Silkworm Genome Consortium.
272. Thevissen K., Kristensen H.-H., Thomma B.P.H.J., et al. Therapeutic potential of antifungal plant and insect defensins. Drug Discov. Today 2007, 12:966-971.
273. Thomas S., Andrews A., Hay P., Bourgoise S. The antimicrobial activity of maggot secretions: results of a preliminary study. J. Tissue Viability 1999, 9:127-132.
274. Thomas T.R.A., Kavlekar D.P., LokaBharathi P.A. Marine drugs from sponge-microbe association - a review. Mar. Drugs 2010, 8:1417-1468.
275. Tiwari H.K., Sen M.R. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect. Dis. 2006, 6:156. 10.1186/1471-2334-6-156.
276. Tonks A.J., Dudley E., Porter N.G., et al. A 5.8-kDa component of Manuka honey stimulates immune cells via TLR4. J. Leukoc. Biol. 2007, 82:1147-1155.
277. Uçkan F., Sinan S., Savasçi S., Ergin E. Determination of venom components from the endoparasitoid wasp Pimpla turionellae L. (Hymenoptera: Ichneumonidae). Ann. Entomol. Soc. Am. 2004, 97:775-780.
278. Uematsu S., Akira S. Toll-like receptors (TLRs) and their ligands. Handbook of Experimental Pharmacology 2008, vol. 118:1-20. Spinger Verlag, Berlin, Heidelberg. S. Bauer, G. Hartmann (Eds.).
279. Van der Plas M.J.A., van der Does A.M., Baldry M., et al. Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes Infect. 2007, 9:507-514.
280. Van der Plas M.J.A., Jukema G.N., Wai S.-W., et al. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. J. Antimicrob. Chemother. 2008, 61:117-122.
281. Van der Plas M.J.A., Baldry M., van Dissel J.T., et al. Maggot secretions suppress pro-inflammatory responses of human monocytes through elevation of cyclic AMP. Diabetologia 2009, 52:1962-1970.
282. Van der Plas M.J.A., van Dissel J.T., Nibbering P.H. Maggot secretions skew monocyte-macrophage differentiation away from a pro-inflammatory to a pro-angiogenic type. PLoS ONE 2009, 10:1-10.
283. Vilcinskas A. Lepidopterans as mini-hosts for human pathogens and as a resource for peptide antibiotics. Molecular Biology and Genetics of the Lepidoptera 2010, 293-305. CRC Press/Taylor & Francis, Boca Raton, Fl. M.R. Goldsmith, F. Marec (Eds.).
284. Vilcinskas A. From traditional maggot therapy to modern biosurgery. Insect Biotechnology 2010, 67-76. Springer, Dordrecht Heidelberg London New York. A. Vilsinskas (Ed.).
285. Vilcinskas, A., 2011. Anti-infective therapeutics from the lepidopteran model host Galleria mellonella. Curr. Pharm. Des. 17 (in press).
286. Vuorenoja S., Rivero-Muller A., Ziecik A.J., et al. Targeted therapy for adrenocortical tumours in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin β conjugate. Endocr. Relat. Cancer 2008, 15:635-648.
287. Wang C., Chen T., Zhang N., et al. Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IκBα Kinase-NFκB. J. Biol. Chem. 2009, 284:3804-3813.
288. Wang, G. (Ed.), 2010. Antimicrobial Peptides (Advances in Molecular and Cellular Biology Series), CABI, ISBN: 1845936574 {norm of matrix} 288 pages, www.ebookee.org/Antimicrobial-Peptides-Advances-in-Molecular-and-Cellular- Biology-Series-_912403.html.
289. Wang G.S. Medical uses of mylabris in ancient China and recent studies. J. Ethnopharmacol. 1989, 26:147-162.
290. Wang K.-R., Zhang B.-Z., Zhang W., et al. Antitumor effects, cell selectivity and structure-activity relationship of a novel antimicrobial peptide polybia-MPI. Peptides 2008, 29:963-968.
291. Wang Q., Liu Y., He H.-J., Zhao X.-F., Wang J.-X. Immune responses of Helicoverpa armigera to different kinds of pathogens. BMC Immunol. 2010, 11:9. 10.1186/1471-2172-11-9.
292. Wang X., Zhang X., Castellot J., et al. Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses. Biomaterials 2008, 29:894-903.
293. Wiesner J., Vilsinskas A. Therapeutic potential of antimicrobial peptides from insects. Insect Biotechnology 2010, 29-65. Springer, Dordrecht Heidelberg London New York. A. Vilsinskas (Ed.).
294. Willadsen P. Anti-tick vaccines. Parasitology 2004, 129:S367-S387.
295. Xu X., Li J., Lu Q., et al. Two families of antimicrobial peptides from wasp (Vespa magnifica) venom. Toxicon 2006, 47:249-253.
296. Yang X., Hu K., Yan G., et al. Fibrinogenolytic components in Tabanid, an ingredient in traditional Chinese medicine and their properties. J. Southwest Agric. Univ. 2000, 22:173-176. (Chinese).
297. Yue W.-F., Deng W., Li X.-H., et al. Silkworm powder containing manganese superoxide dismutase regulated the immunity and inhibited the growth of Hepatoma 22 cell in mice. Mol. Biol. Rep. 2009, 36:323-328.
298. Zaiou M. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J. Mol. Med. 2007, 85:317-329.
299. Zhang C., Peng Y., Wang F., et al. A synthetic cantharidin analog for the enhancement of doxorubicin suppression of stem cell-derived aggressive sarcoma. Biomaterials 2010, 31:9535-9543.
300. Zhang L., Parente J., Harris S.M., et al. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob. Agents Chemother. 2005, 49:2921-2927.
301. Zhang Z., Wang S., Diao Y., et al. Fatty acid extracts from Lucilia sericata larvae promote murine cutaneous wound healing by angiogenic activity. Lipids Health Dis. 2010, 9:24. http://www.lipidworld.com/content/9/1/24.
302. Zhu H.G., Tayeh I., Israel L., Castagna M. Different susceptibility of lung cell lines to inhibitors of tumor promotion and inducers of differentiation. J. Biol. Regul. Homeost. Agents 1991, 5:52-58.
303. Zhu W.L., Nan Y.H., Hahn K.-S., Shin S.Y. Cell selectivity of an antimicrobial peptide melittin diastereomer with D-amino acid in the leucine zipper sequence. J. Biochem. Mol. Biol. 2007, 40:1090-1094.
304. Zimmermann K., Engeser M., Blunt J.W., et al. Pederin-type pathways of uncultivated bacterial symbionts: analysis of O-methyltransferases and generation of a biosynthetic hybrid. J. Am. Chem. Soc. 2009, 131:2780-2781.